Drug intelligence / Profile preview

J591 minibody

Development stage
Unknown
Lead developer
Weill Cornell Medicine
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

The J591 minibody is an engineered antibody fragment designed to target the extracellular domain of Prostate Specific Membrane Antigen (PSMA). It is a homodimer consisting of two single-chain variable fragments (scFv) derived from the deimmunized huJ591 monoclonal antibody, each linked to a human IgG1 CH3 domain via an artificial hinge sequence. This format is optimized for pharmacokinetics, providing rapid tumor localization and faster blood clearance compared to full-length antibodies, which enhances its utility as an imaging agent for positron emission tomography (PET) and single-photon emission computed tomography (SPECT). When conjugated with chelators like DOTA and labeled with radionuclides such as Copper-64, Iodine-124, or Indium-111, it serves as a high-contrast diagnostic tool for staging and monitoring prostate cancer and other solid tumors characterized by PSMA-expressing neovasculature. It also holds potential for radioimmunotherapy when labeled with beta-emitting isotopes like Yttrium-90.

Other names
huJ591 minibodyhuJ-591 minibodyhuJ 591 minibodyanti-PSMA minibodyJ591-DOTA minibodyJ-591-DOTA minibodyJ 591-DOTA minibody124I-J591 minibody64Cu-DOTA-J591 minibody
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on J591 minibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on J591 minibody.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call